Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 434 for “"Cardiac Hypertrophy"”.
-
HETEROCHROMATIN REMODELLING IN CARDIAC HYPERTROPHY
… ventricular assist devices implies a level of cardiac plasticity in the cardiac chromatin. Reports have pointed to epigenetic mechanisms which mediate the heart failure stress-gene response, targeting histone methylation (heterochromatin) for hypertrophy reversal however remains untested. We …
-
Biochemical spects of cardiac hypertrophy
Abstract Not Provided.
-
PHARMACOLOGICAL ASPECTS OF CARDIAC HYPERTROPHY
… have been implicated in the regulation of cardiac hypertrophy. The serial injection of a catecholamine (epinephrine, norepinephrine or isoproterenol) will increase cardiac muscle mass. In a canine model of left ventricular hypertrophy secondary to aortic coarctation, the endogen
-
Investigating Inorganic Arsenic Exposure and Cardiac Hypertrophy
… the possibility that iAS directly induces cardiac remodeling independent of hypertension, we investigated the impact of an environmentally relevant iAS exposure on the structure and function of male and female hearts. Adult male and female C56BL/6J mice were exposed to 615 μg/L NaAsO2 for …
-
The roles of HSP20 in cardiac hypertrophy
Cardiac hypertrophy often develops to compensate for hemodynamic overload and is associated with heart failure. Recent studies have revealed that overexpression and PKA-mediated phosphorylation of heat shock protein 20 (HSP20) at Ser16 can attenuate hypertrophic growth of cardiomyocytes and trigger …
-
The role of PDE2 in cardiac hypertrophy
… growth. Although in its early stages cardiac hypertrophy is considered as an adaptive response, prolonged hypertrophy is associated with a significant increase in the risk of progression to heart failure, one of the leading causes of death in the Western World today. 3’, 5’- cyclic …
-
Advancing Phenotypic Drug Discovery for Cardiac Hypertrophy
… phenotypic screening platform tailored for cardiac hypertrophy that enables efficient lead optimisation and facilitates translation into in vivo models. A mixed neonatal rat cardiac cell culture was established to analyse cardiomyocytes and non-cardiomyocytes responses in parallel. A …
-
Insulin -Like Growth Factors Regulate Cardiac Hypertrophy
… IGF-I or IGF-I receptor antibodies also lead to hypertrophy of adult cardiomyocytes. This induction appears to be mediated by the local production of IGF-II, that this growth factor then stimulates the hypertrophy via an IGF-I receptor-independent, IGF-II-responsive pathway that likely involves …
-
FHL2 Inhibits Calcineurin and Represses Pathological Cardiac Hypertrophy
Stress-induced cardiac hypertrophy is a hallmark feature of pathological remodeling which, left unchecked, predisposes hearts to arrhythmia and failure. FHL2 is a member of the four-and-a-half LIM domain (FHL) family of proteins expressed predominantly in the heart. Targeted disruption of FHL2 …
-
The role of microRNA-378 in cardiac hypertrophy
… mRNA. Heart failure is associated with myocyte hypertrophy and death, due to compensatory pathological remodeling and minimal functional repair along with microRNA deregulation. In this study, we identified candidate microRNAs based on their expression strength in cardiomyocytes and by their …
-
Identification and Characterization of MicroRNAs Modulating Cardiac Hypertrophy
… stimuli; in most cases, a phase of compensated hypertrophy evolves into frank dysfunction and heart failure. To identify microRNAs able to prevent cardiac hypertrophy and preserve cardiac function, we performed a high-content microscopy, high-throughput functional screening for human microRNAs …
-
Investigating the role of Osteopontin in cardiac hypertrophy
… morbidity and mortality in the developed world. Cardiac hypertrophy is an adaptive response to pressure or volume stress, mutations of sarcomeric (or other) proteins, or loss of contractile mass from prior infarction. Hypertrophic growth accompanies many forms of heart disease, including ischemic …
-
Characterization Of Pregnancy Induced Cardiac Hypertrophy In Rats
… compensate for fetal development, resulting in cardiac hypertrophy. For the majority of women, this physiological cardiac hypertrophy resolves following pregnancy. Prolonged cardiac hypertrophy can lead to heart failure. We propose that by studying the biochemical mechanisms that mediate healthy …
-
Ion channel determinants of cardiac hypertrophy and cardiomyopathy
… Corin, in the progression of pressure-overload cardiac hypertrophy. Results show that the absence of TRPV1 in vivo is protective against cardiac hypertrophy under conditions of pressure overload (Chapter 2); however, in the absence of CRACM1 the pathology is exacerbated (Chapter 3). Further, …
-
Transcriptional regulation of cardiac development and cardiac hypertrophy
… transcription factors, is important in areas of cardiac development and cardiac hypertrophy. This study aimed to identify novel post-translational modification mechanisms for FOG-2. Two main areas were investigated. First, novel transcription factor protein partners were pursued and the …
-
The ERK-cascade in the pathophysiology of cardiac hypertrophy
… targets which take part in the development of cardiac hypertrophy. Thereby, targeting this additional phosphorylation is a promising pharmacological approach. In this thesis, an in silico model of ERK cascade in the cardiomyocyte is introduced. The model is a semi-quantitive model and its …
-
b-adrenergic receptors and Erk1/2-mediated cardiac hypertrophy
Chronische Aktivierung von b-Adrenorezeptoren (b-ARs) durch Katecholamine ist ein Stimulus für kardiale Hypertrophie und Herzinsuffizienz. Ebenso führt die Expression von b1-ARs oder Gas-Proteinen in genetisch modifizierten Mäusen zu Hypertrophie und Herzinsuffizienz. Allerdings führt die direkte …
-
Targeting Calcium-Calmodulin Binding to GRK5 in Cardiac Hypertrophy
… in gene regulation, leading to maladaptive cardiac hypertrophy, ventricular remodeling, and contractile dysfunction. The trigger for maladaptation and HF is signaling through the G protein, Gq, and one downstream effector for this pathway is activation of non-canonical activity of G …
Page 1 of 22